Advanced Search

Impact Factor: 1.4

e-ISSN: 2604-7322

Previous issues

Vol. 5. Year 2023. Issue 2.
Pages 89-164 (April-June)
eISSN: 2604-7322








Download full issue
Rec Uk 23 5 2 Cover

EDITORIALS

Class effect in TAVI: the time has come to know if they are all the same

Cristóbal A. Urbano-Carrillo

Servicio de Cardiología, Hospital Regional Universitario de Málaga, Málaga, Spain

REC Interv Cardiol. 2023;5:89-90

3D quantitative coronary angiography based vessel FFR: clinical evidence and future perspectives

Alessandra Scoccia and Joost Daemen

Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands

REC Interv Cardiol. 2023;5:91-93

ORIGINAL ARTICLES

Transcatheter aortic valve implantation using Evolut PRO versus SAPIEN 3 valves: a randomized comparative trial

Heba M. Elnaggar,a Wolfgang Schoels,b Marwan S. Mahmoud,a,b, Yehia T. Kishk,a Matthias Kullmer,b Mohamad Dia,c and Magdy Algowharya

a Cardiology Department, Assiut University Heart Hospital, Assiut University, Assiut, Egypt

b Cardiology Department, Duisburg Heart Center, Duisburg, Germany

c Cardiac Surgery Department, Duisburg Heart Center, Duisburg, Germany

REC Interv Cardiol. 2023;5:94-101

Prospective assessment of clinical outcomes of transcatheter aortic valve implantation in a cohort of patients based on their risk profile

Eduardo Pinar,a, Juan García de Lara,a José Hurtado,a Miguel Robles,b Gunnar Leithold,a Belén Martí-Sánchez,c Paloma González,c Kim Rand,d and Jesús Cuervoe

aDepartamento de Cardiología, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain

bAccounting Department, Servicio Regional de Salud, Murcia, Spain

cEdwards Lifesciences, Valencia, Spain

dHealth Services Research Centre, Akershus University Hospital, Lørenskog, Norway

eAxentiva Solutions, Oviedo, Spain

REC Interv Cardiol. 2023;5:102-109

Clinical outcomes of patients undergoing percutaneous coronary intervention treated with colchicine

César E. Soria Jiménez,a Jorge Sanz Sánchez,b,c Molly Brooke Levine,f Fatima Hayat,d Jerway Chang,e and Héctor M. García-Garcíaf,

aDepartment of Cardiology, MedStar Washington/Georgetown University Hospital Center, Washington, D.C., United States

bDepartment of Cardiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain

cCentro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain

dDepartment of Medicine, MedStar Washington Hospital Center, Washington D.C., United States

eDepartment of Medicine, NYU Langone Health, New York, United States

fSection of Interventional Cardiology, MedStar Washington Hospital Center, Washington D.C., United States

REC Interv Cardiol. 2023;5:110-117

Regional differences in STEMI care in Spain. Data from the ACI-SEC Infarction Code Registry

Oriol Rodríguez-Leor, a,b,c, Ana Belén Cid-Álvarez, d Raúl Moreno, b,e Xavier Rosselló, b,f,g Soledad Ojeda, h Ana Serrador, b,i Ramón López-Palop, j Javier Martín-Moreirasb,k José Ramón Rumoroso, l Ángel Cequier, m Borja Ibáñez, b,f,n Ignacio Cruz-González, b,k Rafael Romaguera, m Sergio Raposeiras, o and Armando Pérez de Prado, p on behalf of the investigators from the Infarction Code Working Group of the ACI-SEC◊

aInstitut del Cor, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

cInstitut de Recerca en Ciències de la Salut Germans Trias i Pujol, Badalona, Barcelona, Spain

dServicio de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain

eServicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain

fLaboratorio Traslacional para la Imagen y Terapia Cardiovascular, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain

gServicio de Cardiología, Institut d’Investigació Sanitària Illes Balears (IdISBa), Hospital Universitari Son Espases, Palma de Mallorca, Islas Baleares, Spain

hServicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain

iServicio de Cardiología, Hospital Clínico de Valladolid, Valladolid, Spain

jServicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain

kServicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

lServicio de Cardiología, Hospital de Galdakao-Usansolo, Galdakao, Vizcaya, Spain

mServicio de Cardiología, Hospital de Bellvitge - IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain

nServicio de Cardiología, IIS-Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

oServicio de Cardiología, Hospital Universitario Álvaro Cunqueiro, Instituto de Investigación Sanitaria Galicia Sur, Vigo, Pontevedra, Spain

pServicio de Cardiología, Hospital de León, León, Spain

◊ The investigators, centers, and organizations involved in the Infarction Code Working Group of the Interventional Cardiology Association of the Spanish Society of Cardiology are shown on the supplementary data.

REC Interv Cardiol. 2023;5:118-128

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach

Marc Figueras Coll,a,b, Andrea Fidalgo García,a Gerard Martí Aguasca,a and Pedro Betrián Blascoa

aUnidad de Hemodinámica Pediátrica, Servicio de Cardiología Pediátrica, Hospital Vall d’Hebrón, Barcelona, Spain

bUnidad de Cardiología Pediátrica, Servicio de Pediatría, Hospital Josep Trueta, Girona, Spain

REC Interv Cardiol. 2023;5:129-135

DEBATE

Debate: Revascularization of non-culprit lesions in ACS: physiology, OCT-guided or both? Perspective from physiology

Mauro Echavarría-Pintoa,b,

aServicio de Cardiología, Hospital General ISSSTE Querétaro, Querétaro, Mexico

bFacultad de Medicina, Universidad Autónoma de Querétaro, Querétaro, Mexico

REC Interv Cardiol. 2023;5:136-138

Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging

Josep Gómez-Lara

aServicio de Cardiología, Hospital Universitari de Bellvitge, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain

REC Interv Cardiol. 2023;5:139-141

SCIENTIFIC LETTERS

Early experience with the FlowTriever thrombectomy system to treat pulmonary embolism

Pablo Salinas,a, María-Eugenia Vázquez-Álvarez,b,c Alfonso Jurado-Román,d Sílvio Leal,e and Mike Huancab,c

aServicio de Cardiología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain

bServicio de Cardiología, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

cCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

dServicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain

eServiço de Cardiologia, Hospital de Santa Cruz/Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal

REC Interv Cardiol. 2023;5:142-150

First experience in Spain with PiCSO therapy in patients with acute myocardial infarction

Pablo Vidal-Calés,a Omar Abdul-Jawad Altisent,a Francesco Spione,a,b Víctor Arévalos,a Manel Sabaté,a and Salvatore Brugalettaa,

aDepartamento de Cardiología Intervencionista, Hospital Clínic de Barcelona, Instituto Clínico Cardiovascular, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain

bDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy

REC Interv Cardiol. 2023;5:142-150

Coronary thrombus after cannabis consumption: the important role of intracoronary imaging modalities

Paulo Duarte Araújo Leite Medeiros, Catarina Quina-Rodrigues, and Carlos Galvão Braga

Cardiology Department, Hospital de Braga, Braga, Portugal

REC Interv Cardiol. 2023;5:142-150

Role of drug-coated balloon in the management of very late stent thrombosis

José Valencia, Francisco Torres-Saura, Fernando Torres-Mezcua, Pascual Bordes, Javier Pineda, and Juan Miguel Ruiz-Nodar

Unidad de Hemodinámica, Servicio de Cardiología, Hospital General Universitario Dr. Balmis, Alicante, Spain

REC Interv Cardiol. 2023;5:142-150

CLINICAL CASE

Intracoronary fibrinolysis as a bailout strategy for massive thrombotic catastrophe

Rui Flores, João Costa, Carlos Braga, Catarina Vieira, and Catarina Quina-Rodrigues

Cardiology Department, Hospital of Braga, Braga, Portugal

REC Interv Cardiol. 2023;5:151-157

Intracoronary fibrinolysis as a bailout strategy for massive thrombotic catastrophe. How would I approach it?

Leire Unzué

Unidad de Cardiología Intervencionista, HM CIEC Madrid (Centro Integral de Enfermedades Cardiovasculares), Hospital Universitario HM Montepríncipe, HM Hospitales, Boadilla del Monte, Madrid, Spain

REC Interv Cardiol. 2023;5:151-157

Intracoronary fibrinolysis as a bailout strategy for massive thrombotic catastrophe. Case resolution

Rui Flores, João Costa, Carlos Braga, Catarina Vieira, and Catarina Quina-Rodrigues

Cardiology Department, Hospital of Braga, Braga, Portugal

REC Interv Cardiol. 2023;5:151-157

IMAGES IN CARDILOGY

The forgotten stent

Daniel Tébar, Alfonso Jurado Román, Santiago Jiménez Valero, Guillermo Galeote, and Raúl Moreno

Unidad de Cardiología Intervencionista, Hospital Universitario La Paz, Madrid, Spain

REC Interv Cardiol. 2023;5:158-159

Atrial mass as a complication following complex percutaneous coronary intervention

Luis Nieto-Roca,a, Rocío Carda Barrio,a Marta Tomás-Mallebrera,b José Antonio Esteban-Chapel,a and María Luisa Martín-Mariscal,a

a Departamento de Cardiología Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

b Departamento de Radiología, Sección de Imagen Cardiaca, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

REC Interv Cardiol. 2023;5:160-161

Transcatheter aortic valve implantation using FEops HEARTguide co-registration

Pablo J. Antúnez-Muiños,a,b, Sergio López-Tejero,a,b Jesús Herrero Garibi,a,b Elena Díaz Peláez,a,b,c Pedro Luis Sánchez Fernández,a,b,c and Ignacio Cruz-Gonzáleza,b,c

aServicio de Cardiología, Hospital Universitario de Salamanca, Salamanca, Spain

bInstituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

cCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

REC Interv Cardiol. 2023;5:162-163